WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totaling 24,485 shares, a decrease of 82.6% from the March 31st total of 140,652 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 107,227 shares, the days-to-cover ratio is presently 0.2 days.

WuXi Biologics (Cayman) Price Performance

Shares of OTCMKTS WXXWY traded down $0.01 during mid-day trading on Friday, reaching $8.54. The company had a trading volume of 32,840 shares, compared to its average volume of 63,502. The stock has a fifty day moving average of $9.22 and a two-hundred day moving average of $9.11. WuXi Biologics has a 12-month low of $5.50 and a 12-month high of $11.21.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.